Invesco (IVZ) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
IVZ jumps 3.1% to $28.80. Closed at $28.80, +3.11% vs the prior close of $27.93. Day range $27.18–$28.81, opened at $27.93.
IVZ daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — IVZ jumps 3.1% to $28.80
- Closed at $28.80, +3.11% vs the prior close of $27.93. Day range $27.18–$28.81, opened at $27.93.
- Volume was 5.34M shares, 1.3x its 50-day average of 4.21M.
- Price is -7.9% vs its 50-day average ($31.29) and +3.1% vs its 200-day average ($27.94).
- 52-week range $20.67–$33.66; today's close sits at 63% of that range, 14.4% below the 52-week high.
Oct 14, 2026 — IVZ slides 3.4% to $27.93, a 3-month low, 5 down days in a row
- Closed at $27.93, -3.42% vs the prior close of $28.92. Day range $27.63–$28.76, opened at $28.54.
- Volume was 4.13M shares, 1.0x its 50-day average of 4.24M.
- Price is -10.9% vs its 50-day average ($31.35) and -0.0% vs its 200-day average ($27.94).
- 52-week range $20.67–$33.66; today's close sits at 56% of that range, 17.0% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — IVZ dips 1.2% to $28.92, a 1-month low, 4 down days in a row
- Closed at $28.92, -1.16% vs the prior close of $29.26. Day range $28.63–$29.52, opened at $29.40.
- Volume was 2.76M shares, 0.6x its 50-day average of 4.28M.
- Price is -8.0% vs its 50-day average ($31.43) and +3.5% vs its 200-day average ($27.93).
- 52-week range $20.67–$33.66; today's close sits at 64% of that range, 14.1% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — IVZ dips 0.8% to $29.26, a 1-month low, 3 down days in a row
- Closed at $29.26, -0.85% vs the prior close of $29.51. Day range $29.07–$29.64, opened at $29.51.
- Volume was 5.18M shares, 1.2x its 50-day average of 4.27M.
- Price is -7.0% vs its 50-day average ($31.47) and +4.8% vs its 200-day average ($27.92).
- 52-week range $20.67–$33.66; today's close sits at 66% of that range, 13.1% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — IVZ dips 1.9% to $29.51, a 1-month low
- Closed at $29.51, -1.93% vs the prior close of $30.09. Day range $29.37–$30.01, opened at $29.95.
- Volume was 5.03M shares, 1.2x its 50-day average of 4.26M.
- Price is -6.3% vs its 50-day average ($31.48) and +5.7% vs its 200-day average ($27.91).
- 52-week range $20.67–$33.66; today's close sits at 68% of that range, 12.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 8, 2026 — IVZ dips 1.3% to $30.09
- Closed at $30.09, -1.34% vs the prior close of $30.50. Day range $29.87–$30.42, opened at $30.09.
- Volume was 3.92M shares, 0.9x its 50-day average of 4.31M.
- Price is -4.4% vs its 50-day average ($31.48) and +7.8% vs its 200-day average ($27.90).
- 52-week range $20.67–$33.66; today's close sits at 73% of that range, 10.6% below the 52-week high.
Oct 7, 2026 — IVZ rises 0.4% to $30.50
- Closed at $30.50, +0.39% vs the prior close of $30.38. Day range $29.86–$30.52, opened at $30.01.
- Volume was 4.45M shares, 1.0x its 50-day average of 4.39M.
- Price is -3.0% vs its 50-day average ($31.44) and +9.4% vs its 200-day average ($27.88).
- 52-week range $20.67–$33.66; today's close sits at 76% of that range, 9.4% below the 52-week high.
Oct 6, 2026 — IVZ dips 0.4% to $30.38
- Closed at $30.38, -0.39% vs the prior close of $30.50. Day range $30.30–$30.86, opened at $30.73.
- Volume was 4.09M shares, 0.9x its 50-day average of 4.46M.
- Price is -3.3% vs its 50-day average ($31.41) and +9.0% vs its 200-day average ($27.86).
- 52-week range $20.67–$33.66; today's close sits at 75% of that range, 9.7% below the 52-week high.
Oct 5, 2026 — IVZ dips 0.5% to $30.50
- Closed at $30.50, -0.52% vs the prior close of $30.66. Day range $30.07–$30.76, opened at $30.67.
- Volume was 3.65M shares, 0.8x its 50-day average of 4.45M.
- Price is -2.9% vs its 50-day average ($31.41) and +9.5% vs its 200-day average ($27.84).
- 52-week range $20.67–$33.66; today's close sits at 76% of that range, 9.4% below the 52-week high.
Oct 2, 2026 — IVZ rises 0.8% to $30.66
- Closed at $30.66, +0.79% vs the prior close of $30.42. Day range $30.44–$31.29, opened at $30.90.
- Volume was 3.88M shares, 0.9x its 50-day average of 4.44M.
- Price is -2.3% vs its 50-day average ($31.40) and +10.2% vs its 200-day average ($27.82).
- 52-week range $20.67–$33.66; today's close sits at 77% of that range, 8.9% below the 52-week high.
Things to know before you trade IVZ
- Last results release: Jul 28, 2026 (8-K Item 2.02). Previous ones: Apr 28, 2026, Jan 27, 2026, Oct 28, 2025. Based on that rhythm, the next report is likely around Oct 27, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.20% (largest 3.4%).
- Liquidity: about 4.78M shares (≈$137.77M) trade per day on average.
- 52-week position: $28.80 vs a range of $20.67–$33.66 (63% of the range).
- Dividends: last ex-dividend date Aug 14, 2026 ($0.215/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 6 sales; latest: Phoebe A Wood sold 3,000 shares on Sep 11, 2026.
- Latest filings: 8-K Oct 9, 2026; 8-K Sep 10, 2026; 8-K Aug 31, 2026.
- Share count: 441.50M shares outstanding (Jun 30, 2026), -1.0% vs a year earlier.
- Listing: NYSE · industry: Investment Advice.
IVZ market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 27.93 | 28.81 | 27.18 | 28.80 | 5.34M |
| Oct 14, 2026 | 28.54 | 28.76 | 27.63 | 27.93 | 4.13M |
| Oct 13, 2026 | 29.40 | 29.52 | 28.63 | 28.92 | 2.76M |
| Oct 12, 2026 | 29.51 | 29.64 | 29.07 | 29.26 | 5.18M |
| Oct 9, 2026 | 29.95 | 30.01 | 29.37 | 29.51 | 5.03M |
| Oct 8, 2026 | 30.09 | 30.42 | 29.87 | 30.09 | 3.92M |
| Oct 7, 2026 | 30.01 | 30.52 | 29.86 | 30.50 | 4.45M |
| Oct 6, 2026 | 30.73 | 30.86 | 30.30 | 30.38 | 4.09M |
| Oct 5, 2026 | 30.67 | 30.76 | 30.07 | 30.50 | 3.65M |
| Oct 2, 2026 | 30.90 | 31.29 | 30.44 | 30.66 | 3.88M |
| Oct 1, 2026 | 30.14 | 30.67 | 29.75 | 30.42 | 5.07M |
| Sep 30, 2026 | 30.41 | 30.54 | 30.15 | 30.16 | 4.13M |
| Sep 29, 2026 | 30.37 | 30.59 | 29.97 | 30.42 | 3.99M |
| Sep 28, 2026 | 30.56 | 30.60 | 29.61 | 30.43 | 5.48M |
| Sep 25, 2026 | 30.85 | 31.11 | 30.42 | 30.92 | 7.38M |
| Sep 24, 2026 | 30.50 | 30.73 | 30.01 | 30.68 | 6.97M |
| Sep 23, 2026 | 30.40 | 30.95 | 30.25 | 30.74 | 4.32M |
| Sep 22, 2026 | 30.70 | 31.63 | 30.35 | 30.85 | 4.79M |
| Sep 21, 2026 | 31.06 | 31.46 | 30.88 | 31.38 | 4.19M |
| Sep 18, 2026 | 30.21 | 30.63 | 29.91 | 30.53 | 6.94M |
About Invesco
Invesco (IVZ) is listed on the NYSE and classified by the SEC under “Investment Advice”. Its business address is in ATLANTA, GA. State of incorporation: Bermuda. Fiscal year ends December 31. SEC CIK 914208.
IVZ board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Sarah Beshar | Director | May 19, 2026 |
| Thomas M Finke | Director | May 19, 2026 |
| Thomas P Gibbons | Director | May 19, 2026 |
| William Francis Jr Glavin | Director | May 19, 2026 |
| Elizabeth S. Johnson | Director | May 19, 2026 |
| Andrew Schlossberg | President and CEO | Jul 7, 2026 |
| Nigel Sheinwald | Director | May 19, 2026 |
| Paula Tolliver | Director | May 19, 2026 |
| G Richard Jr Wagoner | Director | May 19, 2026 |
| Christopher C Womack | Director | May 19, 2026 |
| Phoebe A Wood | Director | Sep 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Stephanie Butcher | Senior Managing Director | Sep 10, 2026 |
| Laura Allison Dukes | Chief Financial Officer | Sep 9, 2026 |
| Shannon A Johnston | SMD and CIOO | Mar 3, 2026 |
| Jeffrey H Kupor | Senior Managing Director | Jul 7, 2026 |
| Andrew Tak Shing Lo | Senior Managing Director | Sep 10, 2026 |
| Andrew Schlossberg | President and CEO | Jul 7, 2026 |
| Douglas J Sharp | Senior Managing Director | Sep 2, 2026 |
| Alan Leonard Smith | SMD and CHRO | Mar 17, 2026 |
| Terry Vacheron | Chief Accounting Officer | Mar 3, 2026 |
| Tony Wong | Senior Managing Director | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 11, 2026 | Phoebe A Wood | Sale | 3,000 | $32.44 |
| Sep 9, 2026 | Andrew Tak Shing Lo | Sale | 100,840 | $32.20 |
| Sep 9, 2026 | Stephanie Butcher | Sale | 45,095 | $32.28 |
| Sep 8, 2026 | Andrew Tak Shing Lo | Sale | 42,530 | $32.85 |
| Sep 4, 2026 | Laura Allison Dukes | Sale | 31,075 | $33.16 |
| Oct 31, 2025 | Douglas J Sharp | Sale | 160,000 | $23.56 |
IVZ financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $6.38B | — | -1.60 | $1.53B |
| Dec 31, 2024 | $6.07B | $538.00M | 1.18 | $1.19B |
| Dec 31, 2023 | $5.72B | $-333.70M | -0.73 | $1.30B |
| Dec 31, 2022 | $6.05B | $683.90M | 1.49 | $703.20M |
| Dec 31, 2021 | $6.89B | $1.39B | 2.99 | $1.08B |
Latest balance sheet: total assets $27.47B, total liabilities $14.00B, cash $915.40M (as of Jun 30, 2026).
IVZ earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 28, 2026 | 8-K Item 2.02 (results) | $29.43 |
| Apr 28, 2026 | 8-K Item 2.02 (results) | $25.86 |
| Jan 27, 2026 | 8-K Item 2.02 (results) | $27.16 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $23.96 |
| Jul 22, 2025 | 8-K Item 2.02 (results) | $21.25 |
| Apr 22, 2025 | 8-K Item 2.02 (results) | $13.49 |
| Jan 28, 2025 | 8-K Item 2.02 (results) | $19.34 |
| Oct 22, 2024 | 8-K Item 2.02 (results) | $18.04 |
| Jul 23, 2024 | 8-K Item 2.02 (results) | — |
| Apr 23, 2024 | 8-K Item 2.02 (results) | — |
| Jan 23, 2024 | 8-K Item 2.02 (results) | — |
| Oct 24, 2023 | 8-K Item 2.02 (results) | — |
More on IVZ
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.